Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID-19) is determined by the presence of cytokine storm

被引：7
|
作者：
Andrianopoulos, Ioannis [1 ]
Papathanasiou, Athanasios [1 ]
Papathanakos, Georgios [1 ]
Chaidos, Aristeidis [2 ]
Koulouras, Vasilios [1 ]
机构：
[1] Univ Hosp Ioannina, Intens Care Unit, Stavros Niarchos Ave, Ioannina 45500, Greece
[2] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 01期
关键词：
D O I：
10.1002/jmv.26209
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [1] Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
    Cure, Erkan
    Kucuk, Adem
    Cumhur Cure, Medine
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (07) : 1177 - 1179
  • [2] Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
    Erkan Cure
    Adem Kucuk
    Medine Cumhur Cure
    Rheumatology International, 2020, 40 : 1177 - 1179
  • [3] Modulation of Covid-19 cytokine storm by tocilizumab
    Boretti, Alberto
    Banik, Bimal
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 823 - 828
  • [4] The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
    Hammock, Bruce D.
    Wang, Weicang
    Gilligan, Molly M.
    Panigrahy, Dipak
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (09): : 1782 - 1788
  • [5] It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)
    Kassis, Christelle
    Wheat, L. Joseph
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (03) : 562 - 562
  • [6] Outcome Heterogeneity in Coronavirus Disease 2019 (COVID-19) Patients Receiving Tocilizumab
    Niu, Man Man
    Cao, Yue
    Li, Rui Xue
    Fan, Guo Zhen
    Hu, Peng
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (08) : 1504 - 1504
  • [7] Tocilizumab Treatment in Severe to Critical Coronavirus Disease 2019 (COVID-19) Patients
    Aparece-Solis, S. O.
    Perez, R. Z.
    Ong, A. Y.
    Canete, M. A.
    Rafanan, A. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [8] Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
    Oliynyk, Oleksandr
    Barg, Wojciech
    Slifirczyk, Anna
    Oliynyk, Yanina
    Gurianov, Vitaliy
    Rorat, Marta
    VIRUSES-BASEL, 2021, 13 (06):
  • [9] Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis
    Hariyanto, Timotius Ivan
    Hardyson, Willie
    Kurniawan, Andree
    DRUG RESEARCH, 2021, 71 (05) : 265 - 274
  • [10] Can tocilizumab calm the cytokine storm of COVID-19?
    Schulert, Grant S.
    LANCET RHEUMATOLOGY, 2020, 2 (08): : E449 - E451
12345